首页 | 本学科首页   官方微博 | 高级检索  
     


Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer
Authors:Ramez Philips MD  Angela Alnemri MD  Dev Amin MD  Jena Patel MD  Michael C. Topf MD  Jennifer M. Johnson MD  PhD  Voichita BarAd MD  Rita Axelrod MD  Athanassios Argiris MD  Christopher Fundakowski MD  Adam J. Luginbuhl MD  David M. Cognetti MD  Joseph M. Curry MD
Affiliation:1. Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA;2. Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA;3. Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA

Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA;4. Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA;5. Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA

Abstract:
Keywords:complications  free flap  head and neck squamous cell carcinoma  immune checkpoint inhibitors  immunotherapy  neoadjuvant therapy  transoral robotic surgery
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号